Geoffrey Ku
机构: Memorial Sloan Kettering Cancer Center
每年引用次数
引用次数
引用: 10,472
H-指数: 37
I10-指数 : 85
出版物: 247
Safety and immunogenicity of a human and mouse gp100 DNA vaccine in a phase I trial of patients with melanoma.
Jedd D. Wolchok , Jedd D. Wolchok , Teresa S. Rasalan , Susan E. Krown
Cancer Immunity Archive 9 ( 1) 5 -5
63
2009
Correlation of clinical and immunological data in a metastatic melanoma patient with heterogeneous tumor responses to ipilimumab therapy
Jedd D. Wolchok , Jedd D. Wolchok , Sacha Gnjatic , Geoffrey Y. Ku
Cancer Immunity Archive 10 ( 1) 1 -1
43
2010
Erratum: Correlation of clinical and immunological data in a metastatic melanoma patient with heterogeneous tumor responses to ipilimumab therapy.
Jedd D. Wolchok , Jedd D. Wolchok , Sacha Gnjatic , Geoffrey Y. Ku
Cancer Immunity Archive 10 ( 1) 5
2010
Phase II Single-arm Study of Durvalumab and Tremelimumab with Concurrent Radiotherapy in Patients with Mismatch Repair-proficient Metastatic Colorectal Cancer.
Ghassan K Abou-Alfa , Taha Merghoub , Nancy E Kemeny , Diane L Reidy-Lagunes
Clinical Cancer Research 27 ( 8) 2200 -2208
30
2021
Phase II Single-arm Study of Durvalumab and Tremelimumab with Concurrent Radiotherapy in Patients with Mismatch Repair-proficient Metastatic Colorectal Cancer.
Ghassan K Abou-Alfa , Taha Merghoub , Nancy E Kemeny , Diane L Reidy-Lagunes
Clinical Cancer Research 27 ( 8) 2200 -2208
30
2021
Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways.
David B Solit , Geoffrey Y. Ku , Steven B. Maron , Francisco Sanchez-Vega
Clinical Cancer Research
2
2021
Management of gastric cancer
Geoffrey Y. Ku , David H. Ilson
Current Opinion in Gastroenterology 30 ( 6) 596 -602
17
2014
Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer.
Sebastian Mondaca , Matthew Margolis , Francisco Sanchez-Vega , Philip Jonsson
Gastric Cancer 22 ( 2) 355 -362
5
2019
Change in chemotherapy during concurrent radiation followed by surgery after a suboptimal positron emission tomography response to induction chemotherapy improves outcomes for locally advanced esophageal adenocarcinoma.
Geoffrey Y. Ku , Anuja Kriplani , Yelena Y. Janjigian , David P. Kelsen
Cancer 122 ( 13) 2083 -2090
17
2016
Successful Treatment of Leptomeningeal Disease in Colorectal Cancer With a Regimen of Bevacizumab, Temozolomide, and Irinotecan
Geoffrey Y. Ku , George Krol , David H. Ilson
Journal of Clinical Oncology 25 ( 13)
16
2007
Chemotherapeutic Options for Gastroesophageal Junction Tumors
Geoffrey Y. Ku , David H. Ilson
Seminars in Radiation Oncology 23 ( 1) 24 -30
9
2013
Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. III. Suppression of graft-versus-host disease in murine allogeneic bone marrow transplantation by the PG27 extract.
John M. Fidler , Geoffrey Y. Ku , Duane Piazza , Rensheng Xu
Transplantation 74 ( 4) 445 -457
26
2002
Adjuvant (postoperative) therapy for esophageal cancer.
Geoffrey Y. Ku , David H. Ilson
Thoracic Surgery Clinics 23 ( 4) 525 -533
9
2013
Phase II trial of cetuximab plus cisplatin and irinotecan in patients with cisplatin and irinotecan-refractory metastatic esophagogastric cancer.
Yelena Y. Janjigian , Geoffrey Y. Ku , Jenny C. Campbell , Manish A. Shah
American Journal of Clinical Oncology 37 ( 2) 126 -130
7
2014
Optimization and validation of a robust human T-cell culture method for monitoring phenotypic and polyfunctional antigen-specific CD4 and CD8 T-cell responses
Yun Lin , Humilidad F. Gallardo , Geoffrey Y. Ku , Hao Li
Cytotherapy 11 ( 7) 912 -922
31
2009
Safety and feasibility of esophagectomy following combined immunotherapy and chemoradiotherapy for esophageal cancer.
Smita Sihag , Geoffrey Y. Ku , Kay See Tan , Samuel Nussenzweig
The Journal of Thoracic and Cardiovascular Surgery 161 ( 3)
37
2021
EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer
Francisco Sanchez-Vega , Jaclyn F. Hechtman , Pau Castel , Geoffrey Y. Ku
Cancer Discovery 9 ( 2) 199 -209
43
2019
Role of Imaging in Esophageal Cancer Management in 2020: Update for Radiologists
Vetri Sudar Jayaprakasam , Randy Yeh , Geoffrey Y. Ku , Iva Petkovska
American Journal of Roentgenology 215 ( 5) 1072 -1084
3
2020
Regorafenib in Combination with First-Line Chemotherapy for Metastatic Esophagogastric Cancer.
Ryan H. Moy , Gustavo Dos Santos Fernandes , Philip Jonsson , Joanne F. Chou
Oncologist 25 ( 1)
9
2020
Role of Neoadjuvant Therapy for Esophageal Adenocarcinoma
Geoffrey Y. Ku , David H. Ilson
Surgical Oncology Clinics of North America 18 ( 3) 533 -546
11
2009